肉毒杆菌中毒

Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285:1059-1070.

• 摘要

Centers for Disease Control and Prevention (CDC). Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. MMWR Morb Mortal Wkly Rep. 2010;59:299.

• 全文
• 摘要

Arnon SS, Schechter R, Maslanka SE, et al. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med. 2006;354:462-471.

• 全文
• 摘要

1.  Centers for Disease Control and Prevention, National Center for Infectious Diseases, Division of Bacterial and Mycotic Diseases. Botulism in the United States, 1899-1996: handbook for epidemiologists, clinicians, and laboratory workers. Atlanta, GA: Centers for Disease Control and Prevention; 1998.

• 全文

2.  Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med. 1998;129:221-228.

• 摘要

3.  Koepke R, Sobel J, Arnon SS. Global occurrence of infant botulism, 1976-2006. Pediatrics. 2008;122:e73-e82.

• 摘要

4.  Giménez JA, Giménez MA, DasGupta BR. Characterization of the neurotoxin isolated from a Clostridium baratii strain implicated in infant botulism. Infect Immun. 1992;60:518-522.

• 全文
• 摘要

5.  Suen JC, Hatheway CL, Steigerwalt AG, et al. Genetic confirmation of identities of neurotoxigenic Clostridium baratii and Clostridium butyricum implicated as agents of infant botulism. J Clin Microbiol. 1988;26:2191-2192.

• 全文
• 摘要

6.  Health Protection Agency. Infant botulism: laboratory reported cases of Clostridium botulinum intoxication reported to the Health Protection Agency Centre for Infections England and Wales 1975-2013. January 2014. http://www.hpa.org.uk/ (last accessed 4 April 2016).

• 全文

7.  Gottlieb SL, Kretsinger K, Tarkhashvili N, et al. Long-term outcomes of 217 botulism cases in the Republic of Georgia. Clin Infect Dis. 2007;45:174-180.

• 全文
• 摘要

8.  Shaffer N, Wainwright RB, Middaugh JP, et al. Botulism among Alaska natives. The role of changing food preparation and consumption practices. West J Med. 1990;153:390-393.

• 全文
• 摘要

9.  Gao QY, Huang YF, Wu JG, et al. A review of botulism in China. Biomed Environ Sci. 1990;3:326-336.

• 摘要

10.  Centers for Disease Control and Prevention (CDC). Botulism associated with commercially canned chili sauce - Texas and Indiana, July 2007. MMWR Morb Mortal Wkly Rep. 2007;56:767-769.

• 全文
• 摘要

11.  Sobel J, Tucker N, Sulka A, et al. Foodborne botulism in the United States, 1990-2000. Emerg Infect Dis. 2004;10:1606-1611.

• 摘要

12.  McLauchlin J, Grant KA, Little CL. Food-borne botulism in the United Kingdom. J Public Health (Oxf). 2006;28:337-342.

• 全文
• 摘要

13.  Health Protection Agency. Guidelines for action in the event of a deliberate release: botulism. March 2009. http://www.hpa.org.uk/ (last accessed 4 April 2016).

• 全文

14.  Health Protection Agency. Foodborne botulism: laboratory reported cases of Clostridium botulinum intoxication reported to the Health Protection Agency Centre for Infections England and Wales 1980-2013. January 2014. http://www.hpa.org.uk/ (last accessed 4 April 2016).

• 全文

15.  Werner SB, Passaro D, McGee J, et al. Wound botulism in California, 1951-1998: a recent epidemic in heroin injectors. Clin Infect Dis. 2000;31:1018-1024.

• 全文
• 摘要

16.  Passaro DJ, Werner SB, McGee J, et al. Wound botulism associated with black tar heroin among injecting drug users. JAMA. 1998;279:859-863.

• 全文
• 摘要

17.  Health Protection Agency. Wound botulism in people who inject drugs: suspected and confirmed cases reported to the Health Protection Agency Centre for Infections, England and Wales 2000-2013. January 2014. http://www.hpa.org.uk/ (last accessed 4 April 2016).

• 全文

18.  Crowner BE, Brunstrom JE, Racette BA. Iatrogenic botulism due to therapeutic botulinum toxin A injection in a pediatric patient. Clin Neuropharmacol. 2007;30:310-313.

• 摘要

19.  Chertow DS, Tan ET, Maslanka SE, et al. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA. 2006;296:2476-2479.

• 全文
• 摘要

20.  Souayah N, Karim H, Kamin SS, et al. Severe botulism after focal injection of botulinum toxin. Neurology. 2006;67:1855-1856.

• 摘要

21.  Wells CL, Wilkin TD. Clostridia: sporeforming anaerobic bacilli. In: Baron S, ed. Medical Microbiology. 4th ed. Galveston, TX: University of Texas Medical Branch; 1996:Chapter 18.

• 摘要

22.  Smith LD. Botulism: the organism, its toxins, the disease. Springfield, IL: Charles C. Thomas; 1977.

23.  Hatheway CL, Johnson EA. Clostridium: the sporebearing anaerobes. In: Collier L, Balows A, Sussman M, eds. Topley & Wilson's microbiology and microbial infections, 9th ed. New York, NY: Oxford University Press; 1998:731-782.

24.  Fu FN, Lomneth RB, Cai S, et al. Role of zinc in the structure and toxic activity of botulinum neurotoxin. Biochemistry. 1998;37:5267-5278.

• 摘要

25.  Lacy DB, Tepp W, Cohen AC, et al. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol. 1998;5:898-902.

• 摘要

26.  Hauschild AH. Clostridium botulinum. In: Doyle MP, ed. Foodborne bacterial pathogens. New York, NY: Marcel Dekker; 1989:112-189.

27.  Arnon S. Infant botulism. In: Feigen RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 4th ed. Philadelphia, PA: WB Saunders; 1998:570-577.

28.  Black JD, Dolly JO. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by receptor-mediated endocytosis. J Cell Biol. 1986;103:535-544.

• 全文
• 摘要

29.  Simpson LL. Peripheral actions of the botulinum toxins. In: Simpson LL, ed. Botulinum neurotoxin and tetanus toxin. San Diego, CA: Academic Press; 1989:153-178.

30.  Blasi J, Binz T, Yamasaki S, et al. Inhibition of neurotransmitter release by clostridial neurotoxins correlates with specific proteolysis of synaptosomal proteins. J Physiol Paris. 1994;88:235-241.

• 摘要

31.  Schiavo G, Benfenati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 1992;359:832-835.

• 摘要

32.  Nowakowski JL, Courtney BC, Bing QA, et al. Production of an expression system for a synaptobrevin fragment to monitor cleavage by botulinum neurotoxin B. J Protein Chem. 1998;17:453-462.

• 摘要

33.  Schiavo G, Santucci A, Dasgupta BR, et al. Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett. 1993;335:99-103.

• 摘要

34.  Sheth AN, Wiersma P, Atrubin D, et al. International outbreak of severe botulism with prolonged toxemia caused by commercial carrot juice. Clin Infect Dis. 2008;47:1245-1251.

• 摘要

35.  Kalka-Moll WM, Aurbach U, Schaumann R, et al. Wound botulism in injection drug users. Emerg Infect Dis. 2007;13:942-943.

• 摘要

36.  Brett MM, Hallas G, Mpamugo O. Wound botulism in the UK and Ireland. J Med Microbiol. 2004;53:555-561.

• 全文
• 摘要

37.  Update zu einer Haufung von Wundbotulismus bei injizierenden Drogenkonsumenten in Nordrhein-Westfalen. Epidemiologisches Bulletin. 2005;(48):453.

38.  Aureli P, Fenicia L, Pasolini B, et al. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis. 1986;154:207-211.

• 摘要

39.  Partikian A, Mitchell WG. Iatrogenic botulism in a child with spastic quadriparesis. J Child Neurol. 2007;22:1235-1237.

• 摘要

40.  Shelley EB, O'Rourke D, Grant K, et al. Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapins. Epidemiol Infect. 2015;143:461-469.

• 摘要

41.  Morris JG Jr, Snyder JD, Wilson R, et al. Infant botulism in the United States: an epidemiologic study of cases occurring outside of California. Am J Public Health. 1983;73:1385-1388.

• 全文
• 摘要

42.  Hughes JM, Blumenthal JR, Merson MH, et al. Clinical features of types A and B food-borne botulism. Ann Intern Med. 1981;95:442-445.

• 摘要

43.  Cherington M. Botulism: update and review. Semin Neurol. 2004;24:155-163.

• 摘要

44.  Istre GR, Compton R, Novotny T, et al. Infant botulism: three cases in a small town. Am J Dis Child. 1986;140:1013-1014.

• 摘要

45.  Long SS. Botulism in infancy. Pediatr Infect Dis. 1984;3:266-271.

• 摘要

46.  Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285:1059-1070.

• 摘要

47.  Notermans S, Nagel J. Assays for botulinum and tetanus toxins. In: Simpson LL, ed. Botulinum neurotoxin and tetanus toxin. San Diego, CA: Academic Press; 1989:319-331.

48.  Dowell VR Jr, McCroskey LM, Hatheway CL, et al. Coproexamination for botulinal toxin and Clostridium botulinum: a new procedure for laboratory diagnosis of botulism. JAMA. 1977;238:1829-1832.

• 摘要

49.  Gutmann L, Bodensteiner J, Gutierrez A. Electrodiagnosis of botulism. J Pediatr. 1992;121:835.

• 摘要

50.  Roman MG, Humber JY, Hall PA, et al. Amplified immunoassay ELISA-ELCA for measuring Clostridium botulinum type E neurotoxin in fish fillets. J Food Prot. 1994;57:985-990.

51.  Shone C, Wilton-Smith P, Appleton N, et al. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay. Appl Environ Microbiol. 1985;50:63-67.

• 全文
• 摘要

52.  Del Torre M, Stecchini ML, Peck MW. Investigation of the ability of proteolytic Clostridium botulinum to multiply and produce toxin in fresh Italian pasta. J Food Prot. 1998;61:988-993.

• 摘要

53.  Rodriguez A, Dezfulian M. Rapid identification of Clostridium botulinum and botulinal toxin in food. Folia Microbiol (Praha). 1997;42:149-151.

• 摘要

54.  Lindström M, Korkeala H. Laboratory diagnostics of botulism. Clin Microbiol Rev. 2006;19:298-314.

• 全文
• 摘要

55.  Sobel J. Botulism. Clin Infect Dis. 2005;41:1167-1173.

• 全文
• 摘要

56.  Sharma SK, Whiting RC. Methods for detection of Clostridium botulinum toxin in foods. J Food Prot. 2005;68:1256-1263.

• 摘要

57.  Pascuzzi RM, Fleck JD. Acute peripheral neuropathy in adults: Guillain-Barre syndrome and related disorders. Neurol Clin. 1997;15:529-547.

• 摘要

58.  Oh SJ, Kim DE, Kuruoglu R, et al. Electrophysiological and clinical correlations in the Lambert-Eaton myasthenic syndrome. Muscle Nerve. 1996;19:903-906.

• 摘要

59.  Centers for Disease Control and Prevention (CDC). Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. MMWR Morb Mortal Wkly Rep. 2010;59:299.

• 全文
• 摘要

60.  Arnon SS, Schechter R, Maslanka SE, et al. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med. 2006;354:462-471.

• 全文
• 摘要

61.  Health Protection Agency. Infant botulism: report of the first treatment by Baby BIG in the UK. November 2007. http://www.hpa.org.uk/ (last accessed 4 April 2016).

• 全文

62.  Santos JI, Swensen P, Glasgow LA. Potentiation of Clostridium botulinum toxin aminoglycoside antibiotics: clinical and laboratory observations. Pediatrics. 1981;68:50-54.

• 摘要

63.  European Agency for the Evaluation of Medicinal Products. EMEA/CPMP guidance document on use of medicinal products for treatment and prophylaxis of biological agents that might be used as weapons of bioterrorism. November 2014. http://www.emea.europa.eu/ (last accessed 4 April 2016).

• 全文

64.  Gangarosa EJ, Donadio JA, Armstrong RW, et al. Botulism in the United States, 1899-1969. Am J Epidemiol. 1971;93:93-101.

• 摘要

65.  Varma JK, Katsitadze G, Moiscrafishvili M, et al. Signs and symptoms predictive of death in patients with foodborne botulism - Republic of Georgia, 1980-2002. Clin Infect Dis. 2004;39:357-362.

• 全文
• 摘要

66.  Glauser TA, Maguire HC, Sladky JT. Relapse of infant botulism. Ann Neurol. 1990;28:187-189.

• 摘要